Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0UJALJ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
MSLN MMAE
|
|||||
| Synonyms |
MSLNMMAE; MSLN MMAE (Anwita Biosciences); MSLN-MMAE
Click to Show/Hide
|
|||||
| Organization |
Anwita Biosciences, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 2 Indication(s)
Pancreatic cancer [ICD11:2C10]
Clinical candidate
Platinum resistant ovarian cancer [ICD11:2C73]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Mesothelin (MSLN)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.